findmyKOL
Clinical trialNCT00377520CompletedPhase 2Interventional

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

SponsorEli Lilly and CompanyEnrollment27Cancer of EndometriumCancer of the EndometriumEndometrial CancerEndometrial NeoplasmsEndometrium CancerGenital Neoplasms, Female+5 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Gynecologic Oncology Group 215-854-0770

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2006
Primary completion
31 Oct 2007
Completion
30 Sept 2008
Last update posted
20 Nov 2009
Registered enrollment
27
Registry id
NCT00377520

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.